TARS
Tarsus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$69.50
+2.10%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 68.21x
- P/E 2028E
- 21.49x
- P/S forward
- 3.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.38x
- Price / sales
- 5.36x
- Price / cash flow
- 40.80x
Enterprise value
- Enterprise value
- $2.9B
- EV / sales
- 4.77x
- EV / EBITDA
- -81.96x
- EV / EBIT
- -59.57x
- Market cap
- $3.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026